Normocytic Normochromic Anemia – Case Study van Schalkwyk.pdfNormocytic Normochromic Anaemia MCV...
Transcript of Normocytic Normochromic Anemia – Case Study van Schalkwyk.pdfNormocytic Normochromic Anaemia MCV...
Normocytic Normochromic Normocytic Normochromic Anaemia Anaemia –– Case StudyCase Study
Adelien van SchalkwykAdelien van SchalkwykMed Lab SouthMed Lab South
June 2009June 2009
Doctorsfindings
PatientSymptoms
Chemistry
Haematology
DIAGNOSIS
Profile of PatientProfile of Patient
MaleMale57 years old57 years oldMalaiseMalaiseFrom rural communityFrom rural community
Hematology ResultsHematology ResultsMarch 2005March 2005
Hb 122 g/lHb 122 g/lPCV 0.36PCV 0.36MCV 83 flMCV 83 flMCH 28 pgMCH 28 pgNo further No further investigations investigations
Chemistry ResultsChemistry ResultsJune 2006June 2006
TP 91 g/lTP 91 g/lAlb 41 g/lAlb 41 g/lGlob 50 g/lGlob 50 g/lNo further No further investigationsinvestigations
Normocytic Normochromic Normocytic Normochromic AnaemiaAnaemia
MCV 80 MCV 80 –– 95 fl95 flMCH > 29 pgMCH > 29 pgHaemolytic anaemiaHaemolytic anaemiaAnaemia of chronic diseaseAnaemia of chronic diseaseAfter acute blood lossAfter acute blood lossRenal diseaseRenal diseaseMixed deficienciesMixed deficienciesBM failure e.g. postBM failure e.g. post--chemotherapy, infiltration chemotherapy, infiltration by carcinoma/myelomaby carcinoma/myeloma
Laboratory Work Up Laboratory Work Up --Normocytic Normochromic Normocytic Normochromic
AnaemiaAnaemiaFBCFBCReticsReticsTotal Iron, TIBC, TransferrinTotal Iron, TIBC, TransferrinFerritinFerritin? sTfR? sTfR
Chemistry ResultsChemistry ResultsMay 2009May 2009
TP 109 g/lTP 109 g/lAlb 38 g/lAlb 38 g/lGlob 71 g/lGlob 71 g/lIgG 6.0 g/lIgG 6.0 g/lIgA 46.0 g/lIgA 46.0 g/lIgM 0.5 g/lIgM 0.5 g/lLaboratory added Laboratory added SPESPE
Serum Protein ElectrophoresisSerum Protein Electrophoresis
AlphaAlpha--11--globulin decreasedglobulin decreasedHeavy monoclonal peak adjacent to Heavy monoclonal peak adjacent to betabeta--globulinsglobulinsImmunoparesisImmunoparesisImmunofixation revealed an IgA Immunofixation revealed an IgA kappa paraproteinkappa paraprotein
ImmunofixationImmunofixation
Other Protein StudiesOther Protein Studies
Urinary Protein 0.12 g/lUrinary Protein 0.12 g/lAlbumin was the predominant protein Albumin was the predominant protein presentpresentBence Jones Protein : A light band of Bence Jones Protein : A light band of intact monoclonal immunoglobulin with intact monoclonal immunoglobulin with attached kappa light chains was detected. attached kappa light chains was detected. No free monoclonal light chain (BJP) was No free monoclonal light chain (BJP) was detecteddetected
Clinical Symptoms Clinical Symptoms --MyelomaMyeloma
Anaemia i.e. lethargy, weakness, pallorAnaemia i.e. lethargy, weakness, pallorBone PainBone PainPathologic fractures & bone lesionsPathologic fractures & bone lesionsSpinal cord compressionSpinal cord compressionHypercalcemia & Renal failureHypercalcemia & Renal failureInfection due to neutropeniaInfection due to neutropeniaBleeding tendency i.e. platelet functionBleeding tendency i.e. platelet functionHyperviscosityHyperviscosityNeurological symptomsNeurological symptoms
Workup for MyelomaWorkup for Myeloma
FBC i.e. Hb, Platelets, WBCFBC i.e. Hb, Platelets, WBCTotal Protein, Albumin, Creatinine, Total Protein, Albumin, Creatinine, CalciumCalciumSPE, Immunofixation SPE, Immunofixation Urine for BJP Urine for BJP ImmunoglobulinsImmunoglobulinsBetaBeta--22--MicroglobulinMicroglobulinCRP vs ESRCRP vs ESR? Serum Viscosity? Serum Viscosity
Other TestsOther Tests
Bone Marrow Aspirate & BiopsyBone Marrow Aspirate & BiopsyXX--ray i.e. skull, long bones, spineray i.e. skull, long bones, spineMRI scanMRI scanSpecialist Tests:Specialist Tests:Cytogenic studies i.e. deletion of Cytogenic studies i.e. deletion of 17p13 on p53 tumor suppressor gene17p13 on p53 tumor suppressor geneChromosome 1 abnormalitiesChromosome 1 abnormalitiesCC--Myc defectsMyc defects
Bone Marrow ResultsBone Marrow Results
NormalNormal
Early Iron Early Iron DeficiencyDeficiencyAnaemia of Chronic Anaemia of Chronic DiseaseDiseaseRenal FailureRenal FailureLiver FailureLiver Failure
AbnormalAbnormal
InfiltrationInfiltrationLeukaemiaLeukaemiaMyelomaMyelomaMetastasesMetastases
Bone Marrow AspirateBone Marrow AspirateCellularity: IncreasedCellularity: IncreasedErythropoiesis: Reduced. NormoblasticErythropoiesis: Reduced. NormoblasticGranulopoiesis: Reduced. Normal morphology & Granulopoiesis: Reduced. Normal morphology & differentiationdifferentiationMegakaryocytes: Reduced numbers. Normal Megakaryocytes: Reduced numbers. Normal morphologymorphologyLymphocytes: NormalLymphocytes: NormalPlasma Cells: Comprise 75% of the cell total Plasma Cells: Comprise 75% of the cell total and include many large and atypical cellsand include many large and atypical cellsIron: Reduced iron stores and erythroblast Iron: Reduced iron stores and erythroblast siderotic granulationsiderotic granulationMyeloidMyeloid--Erythroid Ratio : 3:1Erythroid Ratio : 3:1Comment: Multiple MyelomaComment: Multiple Myeloma
Multiple MyelomaMultiple Myeloma
Proliferation of malignant plasma cellsProliferation of malignant plasma cellsProminent monoclonal protein (paraprotein), Prominent monoclonal protein (paraprotein), unless light chain myelomaunless light chain myelomaNo cure exists No cure exists
Causes of MyelomaCauses of MyelomaGeneticGeneticEnvironmental or occupational i.e. agriculture, Environmental or occupational i.e. agriculture, food, petrochemical industries, exposure to hair food, petrochemical industries, exposure to hair dyesdyesRadiation i.e. Hiroshima victims, Nuclear Plant Radiation i.e. Hiroshima victims, Nuclear Plant employeesemployeesMGUS can develop into MM within 2MGUS can develop into MM within 2--19 y19 yMedian survival with chemotherapy is 3Median survival with chemotherapy is 3--4 years 4 years with a 20% 5 year survivalwith a 20% 5 year survival
Plasma CellsPlasma Cells
Medical CareMedical Care
RadiationRadiationChemotherapy i.e. Vincristine, Adriamycin, Chemotherapy i.e. Vincristine, Adriamycin, Dexamethasone (VAD), Melphalan & PrednisoneDexamethasone (VAD), Melphalan & PrednisoneBiphosphonatesBiphosphonatesInterferonsInterferonsAntibioticsAntibioticsImmunosuppressant agentsImmunosuppressant agentsColonyColony--stimulating factors i.e. Epoetin Alfastimulating factors i.e. Epoetin AlfaTransplantation Transplantation
Other FactorsOther Factors
Patient visited 4Patient visited 4--5 different Doctors i.e. no 5 different Doctors i.e. no follow up regarding essential anemiafollow up regarding essential anemiaNo clinical details to guide laboratory No clinical details to guide laboratory Laboratory results reported without Laboratory results reported without interpretative commentinterpretative commentIn retrospect diagnosis could have been In retrospect diagnosis could have been established in 2005established in 2005Treatment could have started earlier, but ? Real Treatment could have started earlier, but ? Real outcome differenceoutcome difference
Laboratory PuzzleLaboratory Puzzle
ResultResult
SummarySummary
Patient history / symptomsPatient history / symptomsTransfer of patient files i.e. DoctorsTransfer of patient files i.e. DoctorsCommunication e.g. Haematology & Communication e.g. Haematology & ChemistryChemistryAll the pieces of PUZZLE should fit to All the pieces of PUZZLE should fit to reach DIAGNOSISreach DIAGNOSISPatient diagnosed too late Patient diagnosed too late
AcknowledgementsAcknowledgements
Essential Haematology Essential Haematology –– Hoffbrand, Pettit, Hoffbrand, Pettit, MossMossInterpretation of Diagnostic Tests Interpretation of Diagnostic Tests ––WallachWallachMultiple Myeloma Multiple Myeloma -- Grethlein, ThomasGrethlein, ThomasHaematovision 4 MediaHaematovision 4 MediaMedLab SouthMedLab South
THANK YOUTHANK YOU
Any questions ??Any questions ??
THE ENDTHE END